2nd Quarter - Report — EPILEPSY FOUNDATION for EPILEPSY FOUNDATION (2017)

Firm

EPILEPSY FOUNDATION

Client

EPILEPSY FOUNDATION

Income

—

Expenses

$60,000

Expense method

B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health care reform, Medicare, Medicaid, access to care

Lobbyist	Covered position, as disclosed
BEATRIZ DUQUE	—
JENNA A MATHIS New	—
ANGELA OSTROM	—

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); White House Office

Budget/Appropriations BUD

NIH, CDC, FDA and health care/public health appropriations

Lobbyist	Covered position, as disclosed
BEATRIZ DUQUE	—
JENNA A MATHIS New	—
ANGELA OSTROM	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); SENATE; Health & Human Services, Dept of (HHS); White House Office

Civil Rights/Civil Liberties CIV

ADA, employment discrimination, access to education, ending stigma surrounding epilepsy, disability rights

Lobbyist	Covered position, as disclosed
BEATRIZ DUQUE	—
JENNA A MATHIS New	—
ANGELA OSTROM	—

Contacted: Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.